As medical technology continues to evolve, patients today have access to treatment options that are less invasive, offer quicker recovery, and better support long-term quality of life. These ...

Have you been diagnosed with benign prostatic hyperplasia (BPH)? Are you looking for treatment options? If so, HoLEP (Holmium Laser Enucleation of the Prostate) surgery may be the solution for you.

WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American ...

When symptoms arise, Mulroy encourages men to schedule a medical exam to explore underlying causes and treatment options. It’s also important to discuss family history because genetics can be a risk ...

The UK has just seen the first case of treatment for benign prostatic hyperplasia (BPH) with Rezūm™ Water Vapour Therapy using the newly launched Rezūm™ EVO Console at Basingstoke and North Hampshire ...

Teleflex Incorporated announced the presentation of multiple clinical studies at the 2025 American Urological Association Annual Meeting in Las Vegas, highlighting advancements in treatments for ...

The medical field has undergone a quiet revolution during the past three decades. Patients have been brought into the treatment decision process as never before. Gone are the days when the patient was ...

Benign Prostatic Hyperplasia (BPH), or enlarged prostate, is common in men over 50, causing frequent urination and discomfort. While not dangerous, early detection is crucial to prevent complications ...

WAYNE, Pa.--(BUSINESS WIRE)--NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced new data showing that ...

Benign prostatic hyperplasia (BPH) is extremely common in the aging man and may cause significant lower urinary tract symptoms (LUTS) necessitating treatment. Drug treatment is the mainstay of ...